Dear Patients

You will be aware that there have been some changes to the COVID vaccination program as a result of rare side effects that have been linked to the Oxford AstraZenica vaccine.

This AstraZenica vaccine is no longer the preferred vaccine for people under 50. The incidence of thrombosis linked to the vaccine is rare and is less likely in older people.

For the younger age group the Pfeizer vaccine is preferred and will probably be offered in the future.

In the meantime patients aged 50-70 (Phase 2a) will be able to receive the AstraZenca vaccine in general practice from 17 May.

Please see the links below for the latest information about the vaccine and assistance in making your decision.

There will not be time to discuss the vaccine at the vaccine clinic so if you have any concerns please make an appointment with your doctor to decide before you book.

If you decided to proceed you can book at one of our clinics online. Please be aware that the supply of vaccine to general practice is still limited.

https://www.health.gov.au/sites/default/files/documents/2021/04/patient-information-sheet-on-astrazeneca-covid-19-vaccine-and-thrombosis-with-thrombocytopenia-syndrome-tts.pdf

https://www.health.gov.au/sites/default/files/documents/2021/04/covid-19-vaccination-weighing-up-the-potential-benefits-against-risk-of-harm-from-covid-19-vaccine-astrazeneca_0.pdf

Kind Regards

Dr Nadine Perlen
Clinical Director